Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

PDF2 senses specific lipids and regulates root growth and gene expression in Arabidopsis.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Reducing 3α,5α-THP in the hippocampus increases seizures in female rats.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Two new compounds were found to effectively reduce hair growth in mice.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Certain drugs can cause early hair growth in mice by affecting the nerves.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

GLP-1RA therapy may increase the risk of hair loss.

PAR-1 may play a role in hair growth regulation in human hair follicles.

Acid can block TRPV3 from outside the cell but boost its function from inside.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.